Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Angelman Syndrome

• Study to Investigate the Pharmacokinetics and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype
• HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
• An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome
• A Study To Assess Distribution Of RO7248824 In The Central Nervous System Following Single Intrathecal Doses Of [89zr] Labeled RO7248824 In Healthy Male Participants
• A Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of RO7248824 In Participants With Angelman Syndrome
• A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome
• A Study of OV101 in Individuals With Angelman Syndrome (AS)
• An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
• Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome
• Single Dose Pharmacokinetic (PK) Study
• A Study in Adults and Adolescents With Angelman Syndrome
• Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome
• Minocycline in the Treatment of Angelman Syndrome
• A Trial of Levodopa in Angelman Syndrome
• Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
• Dietary Supplements for the Treatment of Angelman Syndrome